Analyst Ratings for Emergent Biosolutions Inc. (EBS)

Updated: 2017-07-27

Analysts covering Emergent Biosolutions Inc. (NYSE:EBS) have given it a consensus rating of Buy. A consensus rating of Buy was previously issued for EBS last month.

A buy rating was issued by 5 analysts, 0 gave an overweight rating, 1 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Several price targets were given for EBS by the analysts covering the stock. The maximum price target given was 50, implying a possible profit of 38.7 percent. The most pessimistic analyst gave a price target of 33, implying a possible loss of -8.46 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. The average change in earnings estimates over the last 90 days is -33.43 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. If we look at the last 90 days instead, we find a net average change of 4.29 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts made negative revisions to their fiscal year's estimates.

The growth rate of EBS's earnings is estimated by analysts to be 27.19 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of EBS is 1.11.

In the trailing 52-weeks, EBS hit 36.64 at the highest peak, while it's lowest trading point was 24.47. Currently the stock is 47.32 percent higher than its low, and below the high by 1.61 percent. EBS has a price/earnings ratio of 30.31. Investors typically compare the P/E ratio to a company's peers in the industry. The EBS value stock report compares EBS to some of its peers using value stock charts. The stock has a market capitalization of $1.48 billion. EBS's next earnings release will be on 0000-00-00, which is days away.